bezafibrate has been researched along with Liver Dysfunction in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beuers, U; Hohenester, S | 1 |
| Poupon, R | 1 |
| Harada, N; Hidaka, M; Inoue, Y; Iwasaki, S; Kawakita, T; Kawano, F; Kiyokawa, T; Matsui, T; Nagakura, S; Onishi, S; Saibara, T; Sakai, T; Takahashi, M; Takemoto, S | 1 |
| Aoki, Y | 1 |
| Kimura, T; Kita, R; Kokuryu, H; Osaki, Y; Takamatsu, S; Tomono, N | 1 |
2 review(s) available for bezafibrate and Liver Dysfunction
| Article | Year |
|---|---|
[Chronic cholestatic liver diseases : Differential diagnosis, pathogenesis and current treatment in adults].
Topics: Adult; Bezafibrate; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholestasis; Diagnosis, Differential; Humans; Liver Diseases; Ursodeoxycholic Acid | 2017 |
[Glucose intolerance in liver diseases].
Topics: Bezafibrate; Diabetes Mellitus; Glucose Intolerance; Humans; Hypolipidemic Agents; Insulin Resistance; Liver Diseases | 2002 |
1 trial(s) available for bezafibrate and Liver Dysfunction
| Article | Year |
|---|---|
Bezafibrate may attenuate biliary damage associated with chronic liver diseases accompanied by high serum biliary enzyme levels.
Topics: Aged; Alkaline Phosphatase; Bezafibrate; Biliary Tract; Chronic Disease; Female; gamma-Glutamyltransferase; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Treatment Outcome | 2006 |
2 other study(ies) available for bezafibrate and Liver Dysfunction
| Article | Year |
|---|---|
Therapeutics Highlights from ILC 2018, the EASL annual congress.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Bezafibrate; Budesonide; CCR5 Receptor Antagonists; Congresses as Topic; Fibroblast Growth Factors; Gastrointestinal Agents; Humans; Imidazoles; Liver Diseases; Pyridazines; Sulfoxides; Uracil; Ursodeoxycholic Acid | 2018 |
Efficacy of bezafibrate for chronic GVHD of the liver after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Bezafibrate; Chronic Disease; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Liver Diseases; Male; Middle Aged; Retrospective Studies; Transplantation, Homologous | 2010 |